Cypherpunk Technologies Surges 52.9% on $50M Zcash Acquisition
By ATTN Desk · Editorial oversight: Sean Han
Introduction to Cypherpunk Technologies Inc
Cypherpunk Technologies Inc (Nasdaq: CYPH) is a digital asset treasury company that changed its name from Leap Therapeutics, Inc on November 12, 2025. The firm is headquartered in Cambridge, Massachusetts, and has transitioned from oncology R&D to accumulating and managing privacy-focused cryptocurrencies. On November 13, 2025, its shares began trading under the new ticker symbol CYPH without interruption.
| Metric | Value |
|---|---|
| Closing Price (Nov 14 2025) | $2.6910 |
| Daily Change | +52.90% |
| Volume | 30,269,888 |
| Exchange | Nasdaq (NAS) |
| Ticker | CYPH |
Corporate Structure and Experience
On November 11, 2025, the board was restructured with Khing Oei appointed as Chairman and Will McEvoy as Chief Investment Officer and board member. Christopher Mirabelli, PhD, stepped down as Chairman but remains on the board. Douglas E. Onsi continues as President and Chief Executive Officer. Cypherpunk completed a $58.88 million private placement led by Winklevoss Capital, which was the sole institutional investor, to fund its Zcash accumulation strategy. Detailed employee counts are not publicly disclosed, but the board additions indicate experience in digital assets and privacy technologies.
Cypherpunk Technologies by Growtika
Recent Developments and News
- Name and Ticker Change (Nov 12–13 2025): Leap Therapeutics rebranded to Cypherpunk Technologies Inc and adopted the ticker CYPH effective November 13, 2025.
- ZEC Acquisition (Nov 12 2025): The company used $50 million of the private-placement proceeds to acquire 203,775.27 ZEC at an average price of $245.37 per coin.
- Leadership Appointments (Nov 11 2025): Khing Oei and Will McEvoy were appointed to the board, supporting the firm’s focus on Zcash and privacy.
Financial and Strategic Analysis
Cypherpunk’s share price increase of 52.90% on November 14, 2025, reflects investor interest in its transition to a crypto-focused balance sheet strategy. By holding over 200,000 ZEC, the company gains exposure to Zcash’s zero-knowledge proof technology and a fixed supply of 21 million coins. Institutional backing from Winklevoss Capital indicates a focus on long-term digital asset management.
Market Position and Industry Context
Cypherpunk operates within a corporate landscape where firms such as MicroStrategy and BitMine have allocated portions of their treasuries to Bitcoin and Ethereum. Zcash, launched in 2016, continues to be recognized as a privacy-preserving blockchain and undergoes developments such as the Halo 2 upgrade for improved scalability. By concentrating on ZEC, Cypherpunk engages with the niche of privacy coins at a time when on-chain confidentiality and selective transparency are gaining attention.
TL;DR
On November 12, 2025, Leap Therapeutics rebranded as Cypherpunk Technologies Inc and announced the acquisition of 203,775.27 ZEC using $50 million from a $58.88 million private placement led by Winklevoss Capital. Khing Oei became Chairman and Will McEvoy was named Chief Investment Officer on November 11, 2025. Trading under the new ticker CYPH began November 13, 2025, and shares closed at $2.6910 (up 52.90%) on November 14, 2025, with 30,269,888 shares exchanged. The company's focus on a privacy coin treasury strategy supports its engagement in blockchain privacy solutions.